AVA and B. Braun Launch Second Fundamentals of Peripheral Intravenous Vascular Access Course

Newswise – Based in the US / New York – February 22, 2022 – The Vascular Access Association (AVA) and B. Braun Medical Inc. (B. Braun) announced the launch of the second of three courses that will provide pre-graduate students in academically approved nursing, medical and allied health programs with hands-on training in the insertion of peripheral intravenous catheters (PIVC). The Fundamentals of Peripheral Intravenous Vascular AccessMT The academic program is free to qualified universities and colleges in the United States and abroad.

PIV 201, which is available for the Spring 2022 semester, builds on the foundation course PIV 101 that was launched for the Fall 2021 semester. The final course, PIV 301, is a certificate course that will be launched in October 2022 and which will focus on advanced courses. vascular access concepts, improving patient outcomes, and critical thinking in vascular access. The complete PIVC placement program is offered free of charge to schools of medicine, nursing, respiratory therapy and other related health care schools. Colleges and universities that wish to include the free program in their Spring 2022 semester can register now via AVA. The program is developed by US and internationally recognized experts in vascular access, infection prevention and legal liability.

Vascular access is the most commonly performed invasive procedure in healthcare,1 with more than 380 million PIVC placements in patients each year in the United States.2 However, between 33% and 69% of PIVCs fail before the end of treatment and more than 50% of adults describe the insertion as moderately painful or worse. 3 Collectively, this can lead to serious consequences for patients, including increased cost and duration of treatment.3 Peripheral vascular injury has been named one of ECRI’s top 10 patient safety concerns for 2021.4 ECRI is an independent, not-for-profit organization focused on healthcare quality, patient safety and evidence-based healthcare advice.

“As the recognized thought leader for the specialty of vascular access, the Association for Vascular Access is committed to providing clinical education and improving patient safety and outcomes, which begins with education. pre-graduate students,” said AVA President Tonja Stevens, BSN, RN, VA-BC™. “PIVC insertions are performed by many different clinicians and professionals, including nurses, physicians, advanced practice practitioners and allied health professionals. This reflects AVA members who work in a variety of work settings such as hospitals, care centres/clinics, alternative care and community settings. We are proud to partner with B. Braun in the development and delivery of this innovative e-learning program to students, faculty, and clinicians to ensure quality patient care and the best clinical practice of this important skill.

“The PIV program will elevate the knowledge and skills of nursing students and nurses in the United States and beyond. I am excited to incorporate this evidence-based program into our pre-licensure BSN program. Christine Vandenhouten, PhD, RN, Chair, Professor of Nursing and Health Studies, University of Wisconsin-Green Bay.

“AVA’s goal is to elevate the knowledge and skills of all health care providers who routinely insert PIVCs, midlines, and central lines as part of their inpatient, outpatient, and outpatient care practices. home,” said Judy Thompson, MSNEd, RN, VA-BC™, AVA Clinical Education Director. “AVA and B. Braun have partnered on this free academic program because patients deserve a safe, infection-free, and comfortable AV procedure from novice clinicians. We want to take fear and discomfort out of the equation for patients and providers. »

“As a leader in infusion therapy, B. Braun believes the failure rate of PIVC insertions is not acceptable,” said Dr. Stephanie Pitts, DNP, RN, CPN, VA-BC™, Director, Strategy, Therapeutic Solutions and Programs at B Braun. “We are pleased to partner with AVA to offer this comprehensive program to enhance education in this important area of ​​patient care, and we look forward to broad participation from schools across the country. Closing the knowledge gap will be essential to raising the bar for PIV care. »

AVA is compiling data on the pilot program and the full program as part of an IRB-approved research study led by Principal Investigator Andrea Owens MSNEd., RN, CRNI®, VA-BC™. “Studies have shown that current training programs are inconsistent between pre-licensing programs and ongoing employer-provided training,” Owens said. “The IRB study will be used to make necessary modifications to the Fundamentals of Peripheral Vascular Access curriculum as a result of the results.”

AVA is committed to making the 3-part Fundamentals course always free for college and university pre-licensing programs in healthcare through the AVA Vascular Access Education program. When schools include the program in their curricula, enrolled students and faculty receive free AVA membership, allowing unlimited access to continuing education in advanced vascular access topics.

The Fundamentals of Peripheral Intravenous Vascular AccessMT will be available to practicing clinicians in October 2022 on AVA Academy for an additional cost. Continuing education credits will be awarded.


The Association for Vascular Access (AVA) is the dominant thought leader in the specialty of vascular access and has a long-standing commitment to the education of clinicians and undergraduate students who represent a wide range of healthcare professions worldwide. Founded in 1985, AVA is at the forefront of protecting and saving lives by establishing best practices and promoting patient advocacy. AVA’s multidisciplinary membership advances research, provides professional and public education to shape practice and improve patient outcomes, and partners with the device manufacturing community to deliver evidence-based innovations in vascular access. To learn more about AVA and the fundamentals of peripheral intravenous vascular access, visit avainfo.org.

Braun Medical Inc., a leader in infusion therapy and pain management, develops, manufactures and markets innovative medical products and services for the healthcare industry. Other key product areas include nutrition, pharmaceutical blends and dialysis. The company is committed to eliminating preventable treatment errors and improving safety for patients, clinicians and the environment. B. Braun Medical is headquartered in Bethlehem, Pennsylvania, and is part of the B. Braun group of companies in the United States, which includes B. Braun Interventional Systems, Aesculap® and CAPS®.

Globally, the B. Braun group of companies employs more than 64,000 employees in 64 countries. Guided by its Sharing Expertise® philosophy, B. Braun continuously exchanges knowledge with its customers, partners and clinicians to solve critical issues of improving care and reducing costs. To learn more about B. Braun Medical, explore our website.



1 Tripathi S, Gladfelter T. Peripheral intravenous catheters in hospitalized patients: Practice, dwell time, and factors affecting dwell times: a single-center retrospective study. J Vasc Access. 30 Mar 2021: 11297298211000874. doi: 10.1177/11297298211000874. Epub ahead of print. PMID: 33784876.

2 iDataResearch. (2020). Suite of reports on the US market for vascular access devices and accessories.

3 Cooke, M., Ullman, A., Ray-Barruel, G., Wallis, M., Corley, A., Rickard, C. (2018). Not “just” an intravenous route: consumer perspectives on peripheral intravenous cannulation (PIVC). An international cross-sectional survey of 25 countries. Plos One. https://doi.org/10.1371/journal.pone.0193436

4 ECRI https://www.ecri.org/press/racial-ethnic-health-disparities-top-patient-safety-concern-for-2021

Comments are closed.